Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;304(6):1194-1201.
doi: 10.1002/ar.24622. Epub 2021 Apr 8.

Zika virus outbreak in Brazil-Lessons learned and perspectives for a safe and effective vaccine

Affiliations
Free article

Zika virus outbreak in Brazil-Lessons learned and perspectives for a safe and effective vaccine

Marco Aurélio Palazzi Sáfadi et al. Anat Rec (Hoboken). 2021 Jun.
Free article

Abstract

Zika virus (ZIKV) is an emerging pathogen of public health concern, associated with a dramatic burden in places where the virus caused outbreaks between 2015 and 2017. In the Americas, the ZIKV was first reported in Brazil and rapidly spread through the Americas. Since its first report, a number of studies have been published as we continue to learn, not only about modes of transmission, but also clinical manifestations, risk of congenital anomalies, including microcephaly and neurological malformations in fetuses born from mothers infected during pregnancy. Interventions to reduce the burden of ZIKV infection are restricted to mosquito control, and for Aedes spp mosquitoes the strategies implemented to that end proved to be unsuccessful so far. Hence the lessons we can learn following the ZIKV epidemics become of paramount importance in the development of drug treatments and in search for a vaccine.

Keywords: Guillain-Barré syndrome; Zika; congenital; congenital Zika syndrome; microcephaly; neurological.

PubMed Disclaimer

Similar articles

Cited by

  • Current Advances in Zika Vaccine Development.
    Wang Y, Ling L, Zhang Z, Marin-Lopez A. Wang Y, et al. Vaccines (Basel). 2022 Oct 28;10(11):1816. doi: 10.3390/vaccines10111816. Vaccines (Basel). 2022. PMID: 36366325 Free PMC article. Review.

References

REFERENCES

    1. Abbink, P., Larocca, R. A., De La Barrera, R. A., Bricault, C. A., Moseley, E. T., Boyd, M., … Barouch, D. H. (2016). Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science, 353(6304), 1129-1132.
    1. Bernatchez, J. A., Tran, L. T., Li, J., Luan, Y., Siqueira-Neto, J. L., & Li, R. (2020). Drugs for the treatment of Zika virus infection. Journal of Medicinal Chemistry, 63(2), 470-489.
    1. Brasil, P., Pereira, J. P., Jr., Moreira, M. E., Ribeiro Nogueira, R. M., Damasceno, L., Wakimoto, M., … Nielsen-Saines, K. (2016). Zika virus infection in pregnant women in Rio de Janeiro - Preliminary report. The New England Journal of Medicine, 16, 742-752.
    1. Brazil. (2020). Ministry of Health. Health Surveillance Secretariat. Boletim Epidemiológico. Monitoramento dos casos de dengue, febre de chikungunya e febre pelo vírus Zika até a Semana Epidemiológica 46 de 2020. Volume 51. 2020. Available from https://www.gov.br/saude/pt-br/media/pdf/2020/dezembro/11/boletim_epidem....
    1. Cao-Lormeau, V.-M., Blake, A., & Mons, S. (2016). Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: A case control study. Lancet, 387, 1531-1539.

LinkOut - more resources